Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Axogen Inc (AXGN) vs Bumble Inc (BMBL) Price & Performance

Axogen IncTrade
Bumble IncTrade

Price performance (Past 24H)

Key statistics

Axogen Inc vs Bumble Inc — how do they compare? Axogen Inc trades at $49.29 (market cap $2.61B), while Bumble Inc trades at $2.59 (market cap $366.87M). The key difference: Axogen Inc is far larger — about 7.1× Bumble Inc's market cap, and Axogen Inc is trading nearer its 52-week high, Bumble Inc nearer its low. Which is the better fit depends on your goals.

AXGNBMBL
Market Cap
$2.61B$366.87M
Sector
TechnologyTechnology
52-Week High
$48.48$7.17
52-Week Low
$14.16$2.70
Enterprise Value
$2.52B$672.73M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Axogen Inc

AXGN trades at $49.10, up 1.82% with strong technical momentum and bullish analyst sentiment. The stock shows robust revenue growth (23.1% in Q2 2026) and raised full-year guidance to $279 million, though profitability remains negative with a -13.36% net margin. Technical indicators show overbought RSI levels but strong moving average support, while institutional ownership and analyst consensus (84% buy ratings) signal confidence in the company's nerve care platform expansion.

The outlook remains positive given strong revenue momentum and regulatory advantages, but investors face execution risks from persistent losses and high valuation multiples. Upside potential exists toward the $54.33 consensus target if margin improvements materialize, though volatility may persist near current resistance levels.

Bumble Inc

Bumble (BMBL) trades at $2.62, down 4.03% on the day, reflecting ongoing investor concerns. The stock is in a bearish technical trend with negative earnings and declining revenue. Recent strategic shifts, including removing the women-first messaging rule and exploring a sale, aim to revive growth amid falling paying users. Valuation ratios like P/S of 0.38 and P/B of 0.71 appear low, but profitability remains weak with a net income margin of -57.96%.

The outlook is cautious; while cost controls and product changes could stabilize the business, persistent losses and competitive pressures pose significant risks. Analyst consensus is mixed with a $3.62 price target, but high institutional selling and bearish sentiment suggest limited near-term upside. Investors should weigh potential turnaround against execution risks and market skepticism.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Axogen Inc

Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.

Read more on AXGN

About Bumble Inc

Bumble Inc is engaged in offering online dating services. The company operates two apps, Bumble and Badoo, where users come on a monthly basis to discover new people and connect with each other.

Read more on BMBL